176 related articles for article (PubMed ID: 26866968)
1. Potent α-amino-β-lactam carbamic acid ester as NAAA inhibitors. Synthesis and structure-activity relationship (SAR) studies.
Nuzzi A; Fiasella A; Ortega JA; Pagliuca C; Ponzano S; Pizzirani D; Bertozzi SM; Ottonello G; Tarozzo G; Reggiani A; Bandiera T; Bertozzi F; Piomelli D
Eur J Med Chem; 2016 Mar; 111():138-59. PubMed ID: 26866968
[TBL] [Abstract][Full Text] [Related]
2. Progress in the development of β-lactams as N-Acylethanolamine Acid Amidase (NAAA) inhibitors: Synthesis and SAR study of new, potent N-O-substituted derivatives.
Petracca R; Ponzano S; Bertozzi SM; Sasso O; Piomelli D; Bandiera T; Bertozzi F
Eur J Med Chem; 2017 Jan; 126():561-575. PubMed ID: 27915171
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationship (SAR) of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters, a class of potent N-acylethanolamine acid amidase (NAAA) inhibitors.
Ponzano S; Bertozzi F; Mengatto L; Dionisi M; Armirotti A; Romeo E; Berteotti A; Fiorelli C; Tarozzo G; Reggiani A; Duranti A; Tarzia G; Mor M; Cavalli A; Piomelli D; Bandiera T
J Med Chem; 2013 Sep; 56(17):6917-34. PubMed ID: 23991897
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation, and 3D QSAR study of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters as N-acylethanolamine acid amidase (NAAA) inhibitors.
Ponzano S; Berteotti A; Petracca R; Vitale R; Mengatto L; Bandiera T; Cavalli A; Piomelli D; Bertozzi F; Bottegoni G
J Med Chem; 2014 Dec; 57(23):10101-11. PubMed ID: 25380517
[TBL] [Abstract][Full Text] [Related]
5. N-(2-oxo-3-oxetanyl)carbamic acid esters as N-acylethanolamine acid amidase inhibitors: synthesis and structure-activity and structure-property relationships.
Duranti A; Tontini A; Antonietti F; Vacondio F; Fioni A; Silva C; Lodola A; Rivara S; Solorzano C; Piomelli D; Tarzia G; Mor M
J Med Chem; 2012 May; 55(10):4824-36. PubMed ID: 22515328
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, structure-activity, and structure-stability relationships of 2-substituted-N-(4-oxo-3-oxetanyl) N-acylethanolamine acid amidase (NAAA) inhibitors.
Vitale R; Ottonello G; Petracca R; Bertozzi SM; Ponzano S; Armirotti A; Berteotti A; Dionisi M; Cavalli A; Piomelli D; Bandiera T; Bertozzi F
ChemMedChem; 2014 Feb; 9(2):323-36. PubMed ID: 24403170
[TBL] [Abstract][Full Text] [Related]
7. 3-Aminoazetidin-2-one derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors suitable for systemic administration.
Fiasella A; Nuzzi A; Summa M; Armirotti A; Tarozzo G; Tarzia G; Mor M; Bertozzi F; Bandiera T; Piomelli D
ChemMedChem; 2014 Jul; 9(7):1602-14. PubMed ID: 24828120
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors.
Tarzia G; Duranti A; Tontini A; Piersanti G; Mor M; Rivara S; Plazzi PV; Park C; Kathuria S; Piomelli D
J Med Chem; 2003 Jun; 46(12):2352-60. PubMed ID: 12773040
[TBL] [Abstract][Full Text] [Related]
9. A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation.
Ribeiro A; Pontis S; Mengatto L; Armirotti A; Chiurchiù V; Capurro V; Fiasella A; Nuzzi A; Romeo E; Moreno-Sanz G; Maccarrone M; Reggiani A; Tarzia G; Mor M; Bertozzi F; Bandiera T; Piomelli D
ACS Chem Biol; 2015 Aug; 10(8):1838-46. PubMed ID: 25874594
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors.
Malamas MS; Farah SI; Lamani M; Pelekoudas DN; Perry NT; Rajarshi G; Miyabe CY; Chandrashekhar H; West J; Pavlopoulos S; Makriyannis A
Bioorg Med Chem; 2020 Jan; 28(1):115195. PubMed ID: 31761726
[TBL] [Abstract][Full Text] [Related]
11. Identification of highly potent N-acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives.
Li Y; Chen Q; Yang L; Li Y; Zhang Y; Qiu Y; Ren J; Lu C
Eur J Med Chem; 2017 Oct; 139():214-221. PubMed ID: 28802121
[TBL] [Abstract][Full Text] [Related]
12. Novel activity-based probes for N-acylethanolamine acid amidase.
Petracca R; Romeo E; Baggelaar MP; Artola M; Pontis S; Ponzano S; Overkleeft HS; van der Stelt M; Piomelli D
Chem Commun (Camb); 2017 Aug; 53(86):11810-11813. PubMed ID: 29035406
[TBL] [Abstract][Full Text] [Related]
13. Activity-Based Probe for N-Acylethanolamine Acid Amidase.
Romeo E; Ponzano S; Armirotti A; Summa M; Bertozzi F; Garau G; Bandiera T; Piomelli D
ACS Chem Biol; 2015 Sep; 10(9):2057-2064. PubMed ID: 26102511
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of potent N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor as anti-inflammatory compounds.
Li Y; Yang L; Chen L; Zhu C; Huang R; Zheng X; Qiu Y; Fu J
PLoS One; 2012; 7(8):e43023. PubMed ID: 22916199
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of new potential inhibitors of N-acylethanolamine hydrolyzing acid amidase.
Saturnino C; Petrosino S; Ligresti A; Palladino C; De Martino G; Bisogno T; Di Marzo V
Bioorg Med Chem Lett; 2010 Feb; 20(3):1210-3. PubMed ID: 20022504
[TBL] [Abstract][Full Text] [Related]
16. Advances in the discovery of N-acylethanolamine acid amidase inhibitors.
Bandiera T; Ponzano S; Piomelli D
Pharmacol Res; 2014 Aug; 86():11-7. PubMed ID: 24798679
[TBL] [Abstract][Full Text] [Related]
17. An unprecedented reversible mode of action of β-lactams for the inhibition of human fatty acid amide hydrolase (hFAAH).
Feledziak M; Michaux C; Lambert DM; Marchand-Brynaert J
Eur J Med Chem; 2013 Feb; 60():101-11. PubMed ID: 23287055
[TBL] [Abstract][Full Text] [Related]
18. Application of computational methods to the design of fatty acid amide hydrolase (FAAH) inhibitors based on a carbamic template structure.
Lodola A; Rivara S; Mor M
Adv Protein Chem Struct Biol; 2011; 85():1-26. PubMed ID: 21920320
[TBL] [Abstract][Full Text] [Related]
19. An Important Role for N-Acylethanolamine Acid Amidase in the Complete Freund's Adjuvant Rat Model of Arthritis.
Bonezzi FT; Sasso O; Pontis S; Realini N; Romeo E; Ponzano S; Nuzzi A; Fiasella A; Bertozzi F; Piomelli D
J Pharmacol Exp Ther; 2016 Mar; 356(3):656-63. PubMed ID: 26769918
[TBL] [Abstract][Full Text] [Related]
20. Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models.
Sasso O; Moreno-Sanz G; Martucci C; Realini N; Dionisi M; Mengatto L; Duranti A; Tarozzo G; Tarzia G; Mor M; Bertorelli R; Reggiani A; Piomelli D
Pain; 2013 Mar; 154(3):350-360. PubMed ID: 23218523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
